Imamura, Keiko <br/><br/>
Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.  [electronic resource] 

 -  Neuroscience letters  Aug 2008 
 - 97-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0304-3940 
<br/><br/><label>Standard No.: </label>10.1016/j.neulet.2008.05.067  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--analogs & derivatives<br/>Animals<br/>Astrocytes--cytology<br/>Benzothiazoles--pharmacology<br/>Brain-Derived Neurotrophic Factor--metabolism<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Cysteine Proteinase Inhibitors--toxicity<br/>Dopamine Agonists--pharmacology<br/>Dose-Response Relationship, Drug<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Microtubule-Associated Proteins--metabolism<br/>Neurons--cytology<br/>Pramipexole<br/>Pregnancy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D1--agonists<br/>Receptors, Dopamine D2--agonists<br/>Tyrosine 3-Monooxygenase--metabolism